114 related articles for article (PubMed ID: 16683526)
1. [Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].
Dai Y; Liu XJ; Zhen YS
Yao Xue Xue Bao; 2006 Jan; 41(1):41-6. PubMed ID: 16683526
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor effects of the immunoconjugate composed of lidamycin and monoclonal antibody 3G11].
Wang FQ; Shang BY; Zhen YS
Yao Xue Xue Bao; 2003 Jul; 38(7):515-9. PubMed ID: 14515796
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor activities of various immunoconjugates composed of lidamycin and anti-type IV collagenase monoclonal antibody].
Feng Y; Zhen YS; Dai Y; Shang BY; Zhang M; He HW; Li BW; Shao RG
Yao Xue Xue Bao; 2007 Jul; 42(7):704-9. PubMed ID: 17882952
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma.
Li L; Huang YH; Li Y; Wang FQ; Shang BY; Zhen YS
World J Gastroenterol; 2005 Aug; 11(29):4478-83. PubMed ID: 16052675
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of monoclonal antibody Fab' fragment-containing immunoconjugates.
Liu X; Zhen Y
Chin Med Sci J; 2002 Mar; 17(1):1-6. PubMed ID: 12894876
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the antitumor activities of immunoconjugates composed of lidamycin and monoclonal antibody fab' fragment with different linkers].
Feng Y; Shao RG; Dai Y; Li BW; He HW; Ren KH
Yao Xue Xue Bao; 2010 May; 45(5):571-5. PubMed ID: 20931757
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody].
Liu X; Shang B; Liu X
Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(4):201-4. PubMed ID: 11798873
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the conjugate composed of a human monoclonal antibody and pingyangmycin on mammary cancer].
Wang WG; Wang SH; Xue YC; Zhen YS
Yao Xue Xue Bao; 1995; 30(8):583-7. PubMed ID: 8571778
[TBL] [Abstract][Full Text] [Related]
9. [Use of monoclonal antibody-pinyangmycin conjugate in experimental regional targeting therapy of tumor].
Wang WG; Xu LN; Zhang SH; Xue YC; Zhen YS
Yao Xue Xue Bao; 1997 Sep; 32(9):669-74. PubMed ID: 11596291
[TBL] [Abstract][Full Text] [Related]
10. [Effect of antibody-targeted chemotherapy with pingyangmycin on prostate cancer cells in vitro].
Chen WZ; Zhang Y; Liang CS; Xie Y; Wen QQ; Gao X
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):406-8. PubMed ID: 18359702
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor effect of lidamycin-containing monoclonal antibody immunoconjugate with downsized-molecule].
Liu XY; Zhen YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):563-7. PubMed ID: 12901099
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of the molecule-downsized immunoconjugate composed of lidamycin and Fab' fragment of monoclonal antibody directed against type IV collagenase.
Fengqiang W; Boyang S; Yongsu Z
Sci China C Life Sci; 2004 Feb; 47(1):66-73. PubMed ID: 15382678
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effect of pingyangmycin on cultured KB cells.
Tai KW; Chang YC; Chou LS; Chou MY
Oral Oncol; 1998 May; 34(3):219-23. PubMed ID: 9692057
[TBL] [Abstract][Full Text] [Related]
14. Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.
Gong JH; Liu XJ; Li Y; Zhen YS
Cancer Chemother Pharmacol; 2012 May; 69(5):1323-32. PubMed ID: 22311160
[TBL] [Abstract][Full Text] [Related]
15. [Immunoscintigraphy of anti-type IV collagenase monoclonal antibody in nude mice bearing human lung cancer xenograft].
Dai Y; Jia B; Wang F; Du J; Shang BY; Zhen YS
Ai Zheng; 2003 Dec; 22(12):1243-8. PubMed ID: 14693044
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor effect of adriamycin conjugated with downsized anti-endoglin monclonal antibody].
Li L; Huang FY; Huang YH; Zhou SL; Guo JL; Zhao HG; Tan GH; Wang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):340-3. PubMed ID: 22812233
[TBL] [Abstract][Full Text] [Related]
17. Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycin.
Miao Q; Shang B; Ouyang Z; Liu X; Zhen Y
Sci China C Life Sci; 2007 Aug; 50(4):447-56. PubMed ID: 17653664
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of a CD13/APN-targeting and hydrolase-resistant conjugate that comprises pingyangmycin and NGR motif-integrated apoprotein.
Li B; Zheng YB; Li DD; Zhen YS
J Pharm Sci; 2014 Apr; 103(4):1204-13. PubMed ID: 24504597
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of verapamil on pingyangmycin-induced cytotoxicity and apoptosis in KB cells.
Ho YC; Tai KW; Chang YC
Oral Dis; 2007 Jan; 13(1):40-4. PubMed ID: 17241428
[TBL] [Abstract][Full Text] [Related]
20. [Cytotoxicity of chymopapain combined with pingyangmycin on mouse hepatoma cell line hepa-6].
Xiaoling C; Jie W; Yong G; Taicheng Y; Jiang X
Zhong Yao Cai; 2004 Apr; 27(4):267-9. PubMed ID: 15307684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
